Poly-ADP-Ribose Polymerase Inhibition Reduces Mesenteric Injury after Cardiopulmonary Bypass*

No abstract is available for this paper.

• Publication year

  2004

• Venue

  The thoracic and cardiovascular surgeon

• Publication date

  2004-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-2004-821274PMID 15573274
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Poly(ADP-ribose) polymerase activation in the reperfused myocardium.

  2004cited by this paper
• Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass.

  2004cited by this paper
• L-arginine protects the mesenteric vascular circulation against cardiopulmonary bypass-induced vascular dysfunction.

  2003cited by this paper
• Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest.

  2003cited by this paper
• Beneficial Effects Of GPI 6150, an Inhibitor of Poly(ADP-Ribose) Polymerase in a Rat Model of Splanchnic Artery Occlusion and Reperfusion

  2002cited by this paper
• Extracorporeal Circulation Induced Microvascular Perfusion Injury of the Small Bowel

  2002cited by this paper
• Mesenteric complications after hypothermic cardiopulmonary bypass with cardiac arrest: underlying mechanisms.

  2002cited by this paper
• Poly(ADP-Ribose) Polymerase Inhibition Reduces Reperfusion Injury After Heart Transplantation

  2002cited by this paper
• Dopexamine attenuates microvascular perfusion injury of the small bowel in pigs induced by extracorporeal circulation.

  2002cited by this paper
• The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors

  2002cited by this paper
• Incidence of gastrointestinal complications in cardiopulmonary bypass patients

  2001cited by this paper
• Mesenteric dysfunction after cardiopulmonary bypass: role of complement C5a.

  2000cited by this paper
• Clinical Investigations: SurgeryInflammatory Response to Cardiopulmonary Bypass: Mechanisms Involved and Possible Therapeutic Strategies

  1997cited by this paper
• Acute mesenteric ischemia following cardiac surgery.

  1997cited by this paper
• Beneficial effects of 3‐aminobenzamide, an inhibitor of poly (ADP‐ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion

  1997cited by this paper
• Effect of cardiopulmonary bypass perfusion protocols on gut tissue oxygenation and blood flow.

  1997cited by this paper
• Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite.

  1997cited by this paper
• DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite.

  1996cited by this paper
• Changes in Systolic and Diastolic Ventricular Function with Cold Cardioplegic Arrest in Man

  1994cited by this paper
• Effects of protamine on vascular smooth muscle of rabbit mesenteric artery.

  1991cited by this paper

• Gastrointestinal injury in cardiopulmonary bypass: current insights and future directions

  2025cites this paper
• Organ-protective effects on the liver and kidney by minocycline in small piglets undergoing cardiopulonary bypass

  2015cites this paper
• Strategies for Pharmacological Organoprotection during Extracorporeal Circulation Targeting Ischemia-Reperfusion Injury

  2015cites this paper
• Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury.

  2011cites this paper
• The world according to poly(ADP-ribose) polymerase (PARP)—update 2006

  2006cites this paper